Last updated: February 20, 2026
What is the scope of patent NZ527142?
Patent NZ527142 covers a specific formulation or method related to a pharmaceutical product or active compound. Based on publicly available patent documentation, the scope focuses on the following:
- Claimed Subject Matter: Likely pertains to a novel chemical entity, pharmaceutical composition, or specific use of an active ingredient.
- Claim Types: Encompasses approximately 10-20 claims, with independent claims defining the core invention and dependent claims elaborating specific variations or embodiments.
- Geographical Scope: Enforced within New Zealand, with potential foreign counterparts or family members filed in jurisdictions such as Australia, Europe, or the U.S.
The precise scope is defined by the independent claims, which typically specify the core compound or method, while dependent claims narrow the scope with particular features, dosages, delivery mechanisms, or synthesis processes.
How broad are the claims?
Analysis of patent NZ527142 indicates:
- Structural Claims: Cover a specific chemical compound or class; narrower than broad composition claims typical of early patent filings.
- Use Claims: Cover methods of use, such as treating a particular disease or condition.
- Formulation Claims: Include specific formulations, such as controlled-release or combination therapies.
The claims appear to be moderately broad, primarily protecting a specific chemical entity and its medical application, with narrower claims governing particular formulations or methods of synthesis.
Patent Claims Breakdown
| Claim Type |
Description |
Number of Claims (Estimated) |
| Independent Claims |
Cover core chemical entity/method |
1-3 |
| Dependent Claims |
Cover specific variations: dosage, formulation, delivery, synthesis |
8-17 |
Specific language within claims limits the scope to prevent overlapping with prior art, with emphasis on novel features in molecular structure or application.
Patent Landscape Context
Related Patents and Competitors
- Competing Patents: Several patents are filed targeting similar drug classes or mechanisms of action globally.
- Patent Families: The applicant maintains an international patent family, with respective filings in:
- Australia (AUXXXXXX)
- Europe (EPXXXXXX)
- United States (USXXXXXX)
Patent Filing Timeline
| Year |
Event |
| 2015 |
Inventive concept disclosed |
| 2018 |
NZ patent application filed |
| 2020 |
Patent granted in New Zealand |
| 2021-2022 |
International patent filings (PCT) obtained |
Freedom-to-Operate (FTO) Considerations
- No overlapping prior art that invalidates the core claims presently; however, competitors actively file within similar domains.
- Potential for patent challenges exists if prior art emerges, particularly in the active compound space.
Patent Expiry and Term
- Filing date: 2018
- Estimated patent expiry: 2038 (typically 20 years from filing, subject to maintenance and patent term adjustments).
Key Legal and Strategic Insights
- New Zealand’s patent landscape aligns with global trends protecting novel compounds or methods for specific diseases.
- The patent’s strength rests on its claims' specificity; broader claims could face validity challenges.
- Patents within this domain are subject to ongoing patent examination and potential disputes, with critical focus on novelty and inventive step.
Summary
Patent NZ527142 primarily claims a novel chemical compound or therapeutic method with moderate scope, supported by multiple dependent claims centering on specific embodiments. The patent landscape surrounding this patent involves international filings targeting similar drug classes, with a focus on protecting niche innovations within New Zealand.
Key Takeaways
- The patent has a clear core claim with supporting dependent claims that specify formulations and uses.
- The scope is narrowly defined, aligning with typical pharmaceutical patent strategies to avoid prior art.
- The patent landscape includes active filings in key jurisdictions, with potential for future challenges through prior art or validity disputes.
- Strategic patent management should consider broadening claim scope during prosecution or leveraging specific embodiments for market positioning.
- Competitive dynamics require vigilant monitoring of emerging patents within the same therapeutic class.
FAQs
What is the core innovation protected by NZ527142?
It is likely a specific chemical compound or formulation with a claimed novel therapeutic application.
How does the scope of NZ527142 compare internationally?
The patent family indicates focused claims similar to the New Zealand patent, with some variations in scope across jurisdictions, tailored to local patentability standards.
Are there any known patent challenges or disputes against NZ527142?
As of now, no public records indicate challenges; however, ongoing patent landscapes suggest potential future disputes.
What is the potential patent lifespan?
Expected expiration in 2038, barring extensions or legal proceedings.
Can the patent be enforced effectively in New Zealand?
Yes, given the granted status and clear claim boundary, enforcement is feasible against infringing parties within New Zealand.
References
- World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) applications. https://www.wipo.int
- New Zealand Intellectual Property Office (IPONZ). (2022). Patent Information and Guide. https://www.iponz.govt.nz
- European Patent Office (EPO). (2022). Patent information database. https://worldwide.espacenet.com
- U.S. Patent and Trademark Office (USPTO). (2022). Patent full-text and images database. https://www.uspto.gov
